After a year of multiple approvals, record-breaking investment and sustained high levels of developers in active clinical trials, the commercial prospect of gene therapies is beginning to become a reality. However, the leading drug developer organizations in this field are telling us that they have little visibility of which contract service providers have the technical experience, capacity and flexibility to meet their demands.

500+ senior decision-makers from these leading companies will come together in Boston at the 6th Annual Gene Therapy for Rare Disorders 2023, actively seeking to forge business partnerships with organizations that can help them accelerate their gene therapy development.

Make the most of the varied networking and limited presentation opportunities on offer to build vital relationships for the future, showcase your solutions, generate new business leads, and source opportunities for partnerships.

Act now to stay ahead of the curve and seize the wealth of opportunity on offer.

Email sponsor@hansonwade.com for more information on the partnership opportunities we offer, bespoke and tailorable to your business goals for hitting commercial objectives for 2023 and beyond.